Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Insmed Incorporated, 3 years.
Insmed Incorporated
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Insmed Incorporated May 13, 202490.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 17, 2026 | Insmed Incorporated | Open-market sale | −5,000 | $127.53 | $637,650 |
| May 13, 2026 | Insmed Incorporated | Grant or award | +3,305 | — | — |
| Mar 3, 2026 | Insmed Incorporated | Gift | −100 | — | — |
| Feb 25, 2026 | Insmed Incorporated | Gift | −1,072 | — | — |
| Feb 25, 2026 | Insmed Incorporated | Gift | +243 | — | — |
| Feb 25, 2026 | Insmed Incorporated | Gift | +243 | — | — |
| Feb 25, 2026 | Insmed Incorporated | Gift | +243 | — | — |
| Feb 25, 2026 | Insmed Incorporated | Gift | +243 | — | — |
| Dec 5, 2025 | Insmed Incorporated | Open-market sale | −20,000 | $205.01 | $4,100,200 |
| Sep 12, 2025 | Insmed Incorporated | Open-market sale | −10,000 | $145.39 | $1,453,900 |
| Sep 11, 2025 | Insmed Incorporated | Gift | −2,000 | — | — |
| Sep 11, 2025 | Insmed Incorporated | Gift | −159 | — | — |
| Sep 11, 2025 | Insmed Incorporated | Gift | +159 | — | — |
| Aug 20, 2025 | Insmed Incorporated | Open-market sale | −10,000 | $129.50 | $1,295,000 |
| Aug 13, 2025 | Insmed Incorporated | Gift | −6,100 | — | — |
Questions about Melvin Sharoky M.D.
What boards is Melvin Sharoky M.D. on?
Melvin Sharoky M.D. sits on the board of Insmed Incorporated.
How long has Melvin Sharoky M.D. served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.